PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31884211-5 2020 The results showed that SFN prevented Cr-induced oxidative stress, histopathological lesions, inflammation, apoptosis, and changes in protein kinase B (Akt) and glycogen synthase kinase 3 beta (GSK-3beta) levels in vivo and in vitro. sulforaphane 24-27 AKT serine/threonine kinase 1 Rattus norvegicus 152-155 31884211-0 2020 Sulforaphane prevents chromium-induced lung injury in rats via activation of the Akt/GSK-3beta/Fyn pathway. sulforaphane 0-12 AKT serine/threonine kinase 1 Rattus norvegicus 81-84 31884211-8 2020 Collectively, this study demonstrates that SFN prevents K2Cr2O7-induced lung toxicity in rats through enhancing Nrf2-mediated exogenous antioxidant defenses via activation of the Akt/GSK-3beta/Fyn signaling pathway. sulforaphane 43-46 AKT serine/threonine kinase 1 Rattus norvegicus 179-182 31217757-0 2019 Sulforaphane Attenuates Endometriosis in Rat Models Through Inhibiting PI3K/Akt Signaling Pathway. sulforaphane 0-12 AKT serine/threonine kinase 1 Rattus norvegicus 76-79 31217757-13 2019 The underlying mechanism revealed that sulforaphane attenuated EM in the rat model by inhibition of PI3K/Akt signaling pathway. sulforaphane 39-51 AKT serine/threonine kinase 1 Rattus norvegicus 105-108 23784363-9 2014 Moreover, sulforaphane repressed the Ang II-induced phosphorylation of Akt, GSK3beta, mTOR, eIF4e, as well as of IkappaBalpha and NF-kappaB. sulforaphane 10-22 AKT serine/threonine kinase 1 Rattus norvegicus 71-74 28110122-8 2017 Otherwise, ERK1/2 and Akt signaling pathways seem to be involved, as the presence of specific inhibitors of these kinases reduced the protective effect of sulforaphane in the presence of 17beta-estradiol. sulforaphane 155-167 AKT serine/threonine kinase 1 Rattus norvegicus 22-25 30835071-0 2019 Sulforaphane potentially attenuates arsenic-induced nephrotoxicity via the PI3K/Akt/Nrf2 pathway in albino Wistar rats. sulforaphane 0-12 AKT serine/threonine kinase 1 Rattus norvegicus 80-83 30835071-3 2019 The current study investigates the protective effects of sulforaphane (SFN) against arsenic-induced renal damage via PI3K/Akt-mediated Nrf2 pathway signaling. sulforaphane 57-69 AKT serine/threonine kinase 1 Rattus norvegicus 122-125 30835071-3 2019 The current study investigates the protective effects of sulforaphane (SFN) against arsenic-induced renal damage via PI3K/Akt-mediated Nrf2 pathway signaling. sulforaphane 71-74 AKT serine/threonine kinase 1 Rattus norvegicus 122-125 30835071-8 2019 Pretreatment with SFN significantly (P < 0.05) attenuated renal ROS, OHdG, lipid peroxidation, and DNA damage, and increased phase II antioxidants via PI3K/Akt-mediated Nrf2 activation in renal tissue. sulforaphane 18-21 AKT serine/threonine kinase 1 Rattus norvegicus 159-162 30835071-9 2019 These results show that dietary supplementation with SFN protects against Ar-induced nephrotoxicity via the PI3K/Akt-mediated Nrf2 signaling pathway in the rat kidney. sulforaphane 53-56 AKT serine/threonine kinase 1 Rattus norvegicus 113-116 31001960-0 2019 Sulforaphane Potentially Ameliorates Arsenic Induced Hepatotoxicity in Albino Wistar Rats: Implication of PI3K/Akt/Nrf2 Signaling Pathway. sulforaphane 0-12 AKT serine/threonine kinase 1 Rattus norvegicus 111-114 31001960-3 2019 The current study was designed to evaluate the protective ability of sulforaphane (SFN) against arsenic (As) induced hepatotoxicity by activation of PI3K induced Akt and Nrf2 mediated signaling pathway. sulforaphane 69-81 AKT serine/threonine kinase 1 Rattus norvegicus 162-165 31001960-3 2019 The current study was designed to evaluate the protective ability of sulforaphane (SFN) against arsenic (As) induced hepatotoxicity by activation of PI3K induced Akt and Nrf2 mediated signaling pathway. sulforaphane 83-86 AKT serine/threonine kinase 1 Rattus norvegicus 162-165 23784363-10 2014 CONCLUSION: Based on our results, sulforaphane attenuates Ang II-induced hypertrophy of H9c2 cardiomyocytes mediated by the inhibition of intracellular signaling pathways including Akt and NF-kappaB. sulforaphane 34-46 AKT serine/threonine kinase 1 Rattus norvegicus 181-184 22417554-0 2011 Cruciferous vegetable phytochemical sulforaphane affects phase II enzyme expression and activity in rat cardiomyocytes through modulation of Akt signaling pathway. sulforaphane 36-48 AKT serine/threonine kinase 1 Rattus norvegicus 141-144